AtriCure Inc <ATRC.O>: UBS cuts target price to $50 from $55
ATRC•Related News
Cinemark Holdings Inc <CNK.N>: Baird Raises Target Price To $40 From $37
CNK•
DTE Energy tops quarterly profit estimates as energy trading unit shines
DTE•
Promis Neurosciences Inc <PMN.O>: Chardan Capital Markets raises target price to $33 from $20
PMN•
Dexcom Inc <DXCM.O>: UBS resumes coverage with Buy rating; target price $96 vs $95
DXCM•
RxSight Inc <RXST.O>: UBS cuts target price to $5.5 from $9
RXST•